8
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Oestradiol Receptors in Non-Neoplastic Gynaecomastic Tissue of Phenotypic Males

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cytoplasmic oestradiol receptors have been reported in breast tumour tissue but not in the uninvolved tissue from the same patients. Since gynaecomastic tissue is highly predisposed to neoplastic transformation, such receptors were looked for in this tissue from 13 phenotypic males of whom 6 had Klinefelter’s syndrome. High affinity saturable binding (K<sub>d </sub>∼ 10<sup>-10</sup> M) of <sup>3</sup>H-oestradiol-170 was found in the breast tissue from 12 of these patients by gel elution and dextran-coated charcoal techniques. The concentration of binding sites were found to range from 16 to 359 fmol/mg cytosol protein.Previous studies by the present authors showing steroid aromatising capacity and the present finding of specific oestradiol receptors in a ‘high-risk tissue’ in the absence of any histologically detectable neoplasms might be relevant in elucidating the natural history of breast cancer in such individuals.

          Related collections

          Author and article information

          Journal
          HRE
          Horm Res Paediatr
          10.1159/issn.1663-2818
          Hormone Research in Paediatrics
          S. Karger AG
          1663-2818
          1663-2826
          1976
          1976
          25 November 2008
          : 7
          : 4-5
          : 193-200
          Affiliations
          Division of Endocrinology, Cancer Research Institute, Bombay
          Article
          178729 Horm Res 1976;7:193–200
          10.1159/000178729
          1017790
          ed22e497-ab17-4c96-953a-29467c899577
          © 1976 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 8
          Categories
          Paper

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Non-neoplastic tissue,Gynaecomastia,Oestradio1-17<italic>β</italic>,Cytosol receptors,Aetiology,Male breast cancer

          Comments

          Comment on this article